Articles related to CLINICAL STUDY

Sugammadex is a safe and effective medication that can be used to reverse rocuronium-induced paralysis and facilitate neurologic examination in patients with neurologic injuries. Pharmacists can play a role in ensuring that patients receive the appropriate dose of sugammadex and that it is administered in a timely manner.

A recent study found that patients who used proton pump inhibitors (PPIs) for more than 4.4 years had a 33% higher risk of developing dementia during the follow-up period.

The study reveals that generic Wixela Inhub is comparable to Advair Diskus in both effectiveness and safety for treating COPD. Consider this cost-effective alternative in your treatment plans.

This longitudinal study offers valuable insights into the complex effects of medical cannabis on quality of life in anxiety patients. Physicians may find the nuanced findings on mental and physical well-being particularly relevant for treatment considerations.

Discover how transcutaneous electrical stimulation could serve as a viable second-line treatment for obstructive sleep apnea patients who are non-compliant with CPAP therapy. The study shows significant improvements in AHI and sleepiness over a three-month period.

Discover how a study from USC reveals that the most common genetic cause of ALS and FTD may have its roots in embryonic development, offering new avenues for early diagnosis and treatment.